top of page
Search

June 2022 // Communication

  • andreachicca797
  • Jun 9, 2022
  • 1 min read

Read about our success story in an article published by NCCR Transcure


In a last newsletter edition from NCCR Transcure, we can look behind the scenes of our technology transfer success story. Prof. Jürg Gertsch together with our CEO Andrea Chicca, illustrate the path that led to the conception and launch of Synendos Therapeutics, a spin-off of NCCR TransCure and University of Bern. Read the full article here:


 



 

Recent Posts

See All
March 2025 // Communication

Synendos has been selected as a finalist of the Swiss Economic Award 2025 in the category Deeptech / Life Sciences. LinkedIn post

 
 
March 2025 // Events & Communication

Synendos has been selected for the Bio-Neuroscience Award for the "Best Pitch" after our CEO Andrea Chicca's presentation on our clinical...

 
 
July 2024 // Communication

Synendos is excited to announce the publication of the latest article written by Andrea Chicca and Jürg Gertsch, “CNS Drug Discovery in...

 
 
bottom of page